Interleukin-12 (IL-12) is a cytokine that has regulatory effects on T
and natural killer (NK) cells and is composed of two disulfide-bonded
subunits, p40 and p35. It was recently reported that supernatants from
cultures of mouse IL-12 (moIL-12) p40-transfected COS cells could inh
ibit IL-12-dependent responses in vitro (Mattner, F., et al., Eur. J.
Immunol. 1993. 23: 2202). We have further characterized the nature of
the inhibitory substance. Purified mouse p40 produced in a baculovirus
expression system was found to consist of two species: the p40 monome
r and a disulfide-linked p40 dimer [(p40)(2)]. The (p40)(2) was 25- to
50-fold more active than the p40 monomer in causing specific, dose-de
pendent inhibition of IL-12-induced mouse concanavalin A (Con A) blast
proliferation and could also inhibit IL-12-induced interferon-gamma (
IFN-gamma) secretion by mouse splenocytes and IL-12-dependent activati
on of mouse NK cells. Competitive binding studies on mouse Con A blast
s showed that (p40)(2) was equally effective as moIL-12 in competing w
ith I-125-labeled moIL-12 ([I-125]moIL-12) for binding to mouse Con A
blasts. However, in contrast to moIL-12, mouse (p40)(2) displayed litt
le ability to compete with I-125-labeled human IL-12 (huIL-12) for bin
ding to high-affinity IL-12 receptors (IL-12R) on human phytohemagglut
inin (PI-IA) blasts and caused little or no inhibition of huIL-12-indu
ced human PHA blast proliferation. Nonetheless, mouse (p40)(2) was equ
ally effective as moIL-12 in competing with [I-125]huIL-12 for binding
to COS cells transfected with the human IL-12R beta subunit and expre
ssing low-affinity IL-12 binding sites. These results suggest that (i)
the majority of the structural determinants required for binding of I
L-12 to its receptor are contained within the p40 subunit, but p35 is
required for signaling, (ii) the p40 subunit of 11,-12 interacts with
the beta subunit of IL-12R, and (iii) (p40)(2) may be a suitable IL-12
antagonist for studying the role of IL-12 in various immune responses
in vice as well as in vitro. Further studies are required to determin
e whether or not (p40)(2) is produced by normal lymphoid cells and is
a physiologic regulator of IL-12 activity.